Does Lombard Medical Inc (EVAR) Represent A Good Investment?

Page 1 of 2

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period that ended September 30, so let’s proceed with the discussion of the hedge fund sentiment on Lombard Medical Inc (NASDAQ:EVAR).

Lombard Medical Inc (NASDAQ:EVAR) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 4 hedge funds’ portfolios at the end of September. At the end of this article we will also compare EVAR to other stocks including Xplore Technologies Corp. (NASDAQ:XPLR), Aldeyra Therapeutics Inc (NASDAQ:ALDX), and Amtech Systems, Inc. (NASDAQ:ASYS) to get a better sense of its popularity.

If you’d ask most investors, hedge funds are assumed to be worthless, old financial vehicles of the past. While there are over 8000 funds with their doors open at present, We look at the crème de la crème of this club, around 700 funds. Most estimates calculate that this group of people watch over most of the smart money’s total asset base, and by observing their matchless picks, Insider Monkey has determined many investment strategies that have historically outpaced the market. Insider Monkey’s small-cap hedge fund strategy defeated the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, we’re going to take a gander at the fresh action regarding Lombard Medical Inc (NASDAQ:EVAR).

What have hedge funds been doing with Lombard Medical Inc (NASDAQ:EVAR)?

At the end of the third quarter, a total of 4 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 0% from the second quarter. With the smart money’s sentiment swirling, there exists an “upper tier” of key hedge fund managers who were upping their stakes meaningfully (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Dennis Purcell’s Aisling Capital has the largest position in Lombard Medical Inc (NASDAQ:EVAR), worth close to $3.2 million, corresponding to 0.6% of its total 13F portfolio. Sitting at the No. 2 spot is Anand Parekh of Alyeska Investment Group, with a $0.6 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Remaining professional money managers that are bullish include Ken Griffin’s Citadel Investment Group, and Efrem Kamen’s Pura Vida Investment.

Page 1 of 2